Similar Outcomes for Robotic, Laparoscopic Prostatectomy

This article originally appeared here.
Share this content:
Similar Outcomes for Robotic, Laparoscopic Prostatectomy
Similar Outcomes for Robotic, Laparoscopic Prostatectomy

For men undergoing routine surgical treatment for localized prostate cancer (PCa), robot-assisted radical prostatectomy (RALP) does not result in better functional outcomes compared with laparoscopic radical prostatectomy (LRP), according to a study. published in the April issue of Urology.

Following the transition from LRP to RALP as the routine operative technique for localized PCa in November 2007, Viktor Berge, MD, PhD, from Oslo University Hospital in Norway, and colleagues compared quality of life for the last 210 consecutive patients operated with LRP and the first 210 consecutive patients operated with RALP. At baseline and at three, 12, and 36 months of follow-up, patients were mailed the University of California Los Angeles-Prostate Cancer Index and Short Form Health Survey-12 questionnaires.

At the 36-month follow-up, the researchers found that 87.9% of the LRP patients and 82.6% of RALP patients had regained baseline urinary function scores, whereas 57.3% and 61.3%, respectively, had regained baseline sexual function scores, the investigators reported in Urology (2013;81:781-786). In both groups, nerve-sparing surgical procedures mitigated the adverse effects on sexual function. Surgical method was not associated with urinary function or sexual function at 36 months.

"Introduction of RALP did not result in improvement of functional outcome," the researchers concluded.

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs